GOALS OF WORK: Complementary and alternative medicines (CAM) use among cancer patients is becoming more prevalent; however, our understanding of factors contributing to patients' decisions to participate in CAM is limited. This study examined correlates of CAM use among colorectal cancer (CRC) survivors, an understudied population that experiences many physical and psychological difficulties. MATERIALS AND METHODS: The sample was 191, predominantly white, CRC survivors (mean age = 59.9 +/- 12.6) who were members of a colon disease registry at a NYC metropolitan hospital. Participants completed assessments of sociodemographic characteristics, psychosocial factors [e.g., psychological functioning, cancer specific distress, social support (SS), quality of life (QOL)], and past CAM use (e.g., chiropractic care, acupuncture, relaxation, hypnosis, and homeopathy). MAIN RESULTS: Seventy-five percent of participants reported using at least one type of CAM; most frequently reported was home remedies (37%). Younger (p < 0.01) or female patients (p < 0.01) were more likely to participate in CAM than their older male counterparts. Among psychosocial factors, poorer perceived SS (p = 0.00), more intrusive thoughts (p < 0.05), and poorer overall perceived QOL (p < 0.05) were associated to CAM use. In a linear regression model (including age, gender, SS, intrusive thoughts, and perceived QOL), only age remained a significant predictor of CAM use. CONCLUSION: These findings demonstrate that CAM use is prevalent among CRC survivors and should be assessed routinely by providers. CAMs may serve as a relevant adjunct to treatment among CRC patients as well as an indication of need for additional SS, especially among younger patients.
GOALS OF WORK: Complementary and alternative medicines (CAM) use among cancerpatients is becoming more prevalent; however, our understanding of factors contributing to patients' decisions to participate in CAM is limited. This study examined correlates of CAM use among colorectal cancer (CRC) survivors, an understudied population that experiences many physical and psychological difficulties. MATERIALS AND METHODS: The sample was 191, predominantly white, CRC survivors (mean age = 59.9 +/- 12.6) who were members of a colon disease registry at a NYC metropolitan hospital. Participants completed assessments of sociodemographic characteristics, psychosocial factors [e.g., psychological functioning, cancer specific distress, social support (SS), quality of life (QOL)], and past CAM use (e.g., chiropractic care, acupuncture, relaxation, hypnosis, and homeopathy). MAIN RESULTS: Seventy-five percent of participants reported using at least one type of CAM; most frequently reported was home remedies (37%). Younger (p < 0.01) or female patients (p < 0.01) were more likely to participate in CAM than their older male counterparts. Among psychosocial factors, poorer perceived SS (p = 0.00), more intrusive thoughts (p < 0.05), and poorer overall perceived QOL (p < 0.05) were associated to CAM use. In a linear regression model (including age, gender, SS, intrusive thoughts, and perceived QOL), only age remained a significant predictor of CAM use. CONCLUSION: These findings demonstrate that CAM use is prevalent among CRC survivors and should be assessed routinely by providers. CAMs may serve as a relevant adjunct to treatment among CRCpatients as well as an indication of need for additional SS, especially among younger patients.
Authors: R Moschèn; G Kemmler; H Schweigkofler; B Holzner; M Dünser; R Richter; W W Fleischhacker; B Sperner-Unterweger Journal: Support Care Cancer Date: 2001-06 Impact factor: 3.603
Authors: Jennifer S Yates; Karen M Mustian; Gary R Morrow; Leslie J Gillies; Devi Padmanaban; James N Atkins; Brian Issell; Jeffrey J Kirshner; Lauren K Colman Journal: Support Care Cancer Date: 2005-02-15 Impact factor: 3.603
Authors: Suzanne C Tough; David W Johnston; Marja J Verhoef; Keith Arthur; Heather Bryant Journal: Altern Ther Health Med Date: 2002 Mar-Apr Impact factor: 1.305
Authors: Wolfgang Spiegel; Thomas Zidek; Christian Vutuc; Manfred Maier; Karin Isak; Michael Micksche Journal: Wien Klin Wochenschr Date: 2003-10-31 Impact factor: 1.704
Authors: Michael McCulloch; Michael Broffman; Mark van der Laan; Alan Hubbard; Lawrence Kushi; Donald I Abrams; Jin Gao; John M Colford Journal: Integr Cancer Ther Date: 2011-09-30 Impact factor: 3.279
Authors: Kristen Arthur; Juan Carlos Belliard; Steven B Hardin; Kathryn Knecht; Chien-Shing Chen; Susanne Montgomery Journal: Integr Cancer Ther Date: 2012-02-07 Impact factor: 3.279
Authors: Nikki A Hawkins; Tenbroeck Smith; Luhua Zhao; Juan Rodriguez; Zahava Berkowitz; Kevin D Stein Journal: J Cancer Surviv Date: 2009-11-10 Impact factor: 4.442
Authors: Ketty Mobed; Raymond Liu; Susan Stewart; Margaret Wrensch; Lucie McCoy; Terri Rice; Michael Prados; Susan Chang Journal: J Support Oncol Date: 2009 Nov-Dec
Authors: Elke Jeschke; Thomas Ostermann; Horst C Vollmar; Matthias Kröz; Angelina Bockelbrink; Claudia M Witt; Stefan N Willich; Harald Matthes Journal: BMC Fam Pract Date: 2009-12-10 Impact factor: 2.497